The existing transitional justice (TJ) system fails to open avenues for social justice as it is envisioned and demanded at the local level. Rather, the current system creates a gap between the ...

Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million. Maze ...